GPT and anemia (phenotype): The most common organ-specific adverse effects were high bilirubin concentrations (78.9%), high creatinine concentrations (78.9%), anemia (57.9%), thrombocytopenia (52.6%), high alanine aminotransferase concentrations (52.6%), and high blood urea nitrogen (52.6%).